Ali-Jackson Kamil bought RIGL
May 15, 2026 · Form 4 insider transaction
Ali-Jackson Kamil bought 5,750 shares of Rigel Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,750
Price
$0.00
Total value
N/A
InsiderAli-Jackson Kamil
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 15, 2026
Filing dateMay 19, 2026
Shares owned after15,125
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.